Lymph node stromal cells constrain immunity via MHC class II self-antigen presentation

Non-hematopoietic lymph node stromal cells shape immunity by inducing MHC-I-dependent deletion of self-reactive CD8 T cells and MHC-II-dependent anergy of CD4 T cells. In this study, we show that MHC-II expression on lymph node stromal cells is additionally required for homeostatic maintenance of re...

Full description

Saved in:
Bibliographic Details
Published ineLife Vol. 3
Main Authors Baptista, Antonio P, Roozendaal, Ramon, Reijmers, Rogier M, Koning, Jasper J, Unger, Wendy W, Greuter, Mascha, Keuning, Eelco D, Molenaar, Rosalie, Goverse, Gera, Sneeboer, Marlous M S, den Haan, Joke M M, Boes, Marianne, Mebius, Reina E
Format Journal Article
LanguageEnglish
Published England eLife Sciences Publications Ltd 19.11.2014
eLife Sciences Publications, Ltd
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Non-hematopoietic lymph node stromal cells shape immunity by inducing MHC-I-dependent deletion of self-reactive CD8 T cells and MHC-II-dependent anergy of CD4 T cells. In this study, we show that MHC-II expression on lymph node stromal cells is additionally required for homeostatic maintenance of regulatory T cells (Tregs) and maintenance of immune quiescence. In the absence of MHC-II expression in lymph node transplants, i.e. on lymph node stromal cells, CD4 as well as CD8 T cells became activated, ultimately resulting in transplant rejection. MHC-II self-antigen presentation by lymph node stromal cells allowed the non-proliferative maintenance of antigen-specific Tregs and constrained antigen-specific immunity. Altogether, our results reveal a novel mechanism by which lymph node stromal cells regulate peripheral immunity.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
These authors contributed equally to this work.
Infectious Diseases and Vaccines Therapeutic Area, Janssen Pharmaceutical Companies of Johnson and Johnson, Leiden, Netherlands.
ISSN:2050-084X
2050-084X
DOI:10.7554/elife.04433